Ignite Creation Date:
2025-12-24 @ 11:39 PM
Ignite Modification Date:
2026-01-04 @ 5:19 PM
Study NCT ID:
NCT06001151
Status:
RECRUITING
Last Update Posted:
2023-08-21
First Post:
2023-08-12
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Cadonilimab (AK104) Plus Chemotherapy as First-line Treatment in Non-squamous Non-Small Cell Lung Cancer (NSCLC) Patients With Programmed Cell Death Ligand 1 (PD-L1) Negative
Sponsor:
Organization: